Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Li Kuang

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Allergy and Asthma Proceedings|December 6, 2021
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocolGayatri B Patel, Krishan D Chhiba, Michael M Chen, et al.
The Journal of Allergy and Clinical Immunology|June 20, 2020
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19Krishan D Chhiba, Gayatri B Patel, Thanh Huyen T Vu, et al.
The New England Journal of Medicine|April 4, 2019
Benralizumab for <i>PDGFRA</i>-Negative Hypereosinophilic SyndromeFei Li Kuang, Fanny Legrand, Michelle Makiya, et al.
Allergy|August 16, 2022
Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disordersMichelle A Makiya, Paneez Khoury, Fei Li Kuang, et al.
The Journal of Allergy and Clinical Immunology|August 7, 2024
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meetingBenjamin L Wright, Juan Pablo Abonia, Edsel M Abud, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Allergy and Asthma Proceedings|December 6, 2021
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocolGayatri B Patel, Krishan D Chhiba, Michael M Chen, et al.
The Journal of Allergy and Clinical Immunology|June 20, 2020
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19Krishan D Chhiba, Gayatri B Patel, Thanh Huyen T Vu, et al.
The New England Journal of Medicine|April 4, 2019
Benralizumab for <i>PDGFRA</i>-Negative Hypereosinophilic SyndromeFei Li Kuang, Fanny Legrand, Michelle Makiya, et al.
Allergy|August 16, 2022
Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disordersMichelle A Makiya, Paneez Khoury, Fei Li Kuang, et al.
The Journal of Allergy and Clinical Immunology|August 7, 2024
Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meetingBenjamin L Wright, Juan Pablo Abonia, Edsel M Abud, et al.
Pageof 3